Biogen Inc
Cheaper medicines, free beach trips: U.S. health plans tap prescriptions that feds say are illegal
Every step is a struggle for Bruce Zimmerman, whose health has been deteriorating since he was diagnosed with multiple sclerosis eight years ago. In 2019, Zimmerman said, his then-employer offered him an opportunity that sounded irresistible: He and his wife, Becky, could take all-expense-paid trips to the Cayman Islands and the Bahamas to retrieve the medication […]
Read More
Stocks making the biggest moves midday: Generac, Shake Shack, Microsoft, Meta & more
Check out the companies making the biggest moves midday: Generac — The generator company gained 8% after Bank of America raised its price target on the stock, highlighting the company’s entry into data centers . Baxter International — Shares fell around 20% after the health-care company reported weaker-than-expected results for the second quarter. Baxter reported […]
Read More
Stocks making the biggest premarket moves: CVS, Comcast, Meta, Norwegian Cruise and more
Check out the companies making the biggest moves in premarket trading: CVS Health — The stock popped 7% after the drugstore chain reported an earnings and revenue beat for its second quarter. The company also boosted its adjusted profit outlook, now expecting a range of $6.30 to $6.40 per share for fiscal 2025, up from […]
Read More
S&P 500 futures rise after Meta and Microsoft post quarterly beats: Live updates
A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., July 30, 2025. Jeenah Moon | Reuters S&P 500 futures and Nasdaq 100 futures rose on Wednesday evening following solid earnings reports from tech giants Microsoft and Meta Platforms. S&P 500 futures jumped 0.7%, and Nasdaq 100 […]
Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]
Read More
FDA taps biotech industry veteran as RFK Jr.’s top drug regulator
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. Jason Reed | Reuters The Food and Drug Administration said on Monday it has appointed former biotech executive George Tidmarsh as the agency’s top drug regulator. Tidmarsh, an adjunct professor of pediatrics and neonatology […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer’s treatment Leqembi, saw growth. But the biotech company’s […]
Read More
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. A bumpy ride Stock futures climbed Monday as investors digested the latest phase in a brewing global trade war. The three major U.S. averages dipped last week. The S&P 500 slipped by 0.2%, while the Dow Jones Industrial Average […]
Read More
Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb believes Alzheimer’s is the largest market for its newly approved schizophrenia drug, Cobenfy, which it expects to eventually generate billions of dollars in revenue. In […]
Read More